{"transactions":[{"id":723990,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34817,"kind":"person","name":"Campbell Shannon","position":1,"cik":"0002018966","reported_name":"Campbell Shannon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-29T20:32:56.000Z","date":"2026-06-26","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 26, 2027 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.71,"expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0002018966-26-000007","document":"form4-06292026_080653.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000201896626000007/form4-06292026_080653.xml","form_type":"4"}},{"id":761871,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":34817,"kind":"person","name":"Campbell Shannon","position":1,"cik":"0002018966","reported_name":"Campbell Shannon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-27T20:11:29.000Z","date":"2026-05-26","kind":"grant","planned":false,"acquired":true,"shares":114200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The restricted stock units (\"RSUs\") were granted by the Issuer pursuant to the Issuer's Non-Employee Director Compensation Program. One third of the RSUs will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":114200,"source":{"system":"sec-edgar","filing":"0002018966-26-000005","document":"wk-form4_1779912686.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000201896626000005/wk-form4_1779912686.xml","form_type":"4"}},{"id":1113455,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34817,"kind":"person","name":"Campbell Shannon","position":1,"cik":"0002018966","reported_name":"Campbell Shannon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T22:24:33.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":30550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 12, 2026 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":30550,"derivative":{"exercise_price":2.43,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":30550},"source":{"system":"sec-edgar","filing":"0001415889-25-017053","document":"form4-06122025_100629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588925017053/form4-06122025_100629.xml","form_type":"4"}},{"id":1330837,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34817,"kind":"person","name":"Campbell Shannon","position":1,"cik":"0002018966","reported_name":"Campbell Shannon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-16T21:34:15.000Z","date":"2024-12-13","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":2.5,"value":11250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on December 12, 2024."}],"balance_after":8865,"source":{"system":"sec-edgar","filing":"0001415889-24-029481","document":"form4-12162024_091212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588924029481/form4-12162024_091212.xml","form_type":"4"}},{"id":1401618,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34817,"kind":"person","name":"Campbell Shannon","position":1,"cik":"0002018966","reported_name":"Campbell Shannon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-20T20:24:43.000Z","date":"2024-09-20","kind":"grant","planned":false,"acquired":true,"shares":2354,"price":4.78,"value":11252.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on September 19, 2024."}],"balance_after":4365,"source":{"system":"sec-edgar","filing":"0001415889-24-023757","document":"form4-09202024_080939.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588924023757/form4-09202024_080939.xml","form_type":"4"}},{"id":1472087,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34817,"kind":"person","name":"Campbell Shannon","position":1,"cik":"0002018966","reported_name":"Campbell Shannon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-21T20:20:35.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":2011,"price":4.98,"value":10014.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on June 20, 2024."}],"balance_after":2011,"source":{"system":"sec-edgar","filing":"0001415889-24-017842","document":"form4-06212024_080631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588924017842/form4-06212024_080631.xml","form_type":"4"}},{"id":1488468,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34817,"kind":"person","name":"Campbell Shannon","position":1,"cik":"0002018966","reported_name":"Campbell Shannon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T21:52:12.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":30550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 6, 2025 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":30550,"derivative":{"exercise_price":4.65,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":30550},"source":{"system":"sec-edgar","filing":"0001415889-24-015821","document":"form4-06062024_090608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588924015821/form4-06062024_090608.xml","form_type":"4"}},{"id":1542587,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34817,"kind":"person","name":"Campbell Shannon","position":1,"cik":"0002018966","reported_name":"Campbell Shannon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-12T21:29:32.000Z","date":"2024-04-10","kind":"grant","planned":false,"acquired":true,"shares":61100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in thirty-six (36) equal monthly installments, with the first installment vesting on May 10, 2024, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":61100,"derivative":{"exercise_price":4.98,"expiration_date":"2034-04-09","underlying":"Common Stock","underlying_shares":61100},"source":{"system":"sec-edgar","filing":"0001415889-24-010770","document":"form4-04122024_090409.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588924010770/form4-04122024_090409.xml","form_type":"4"}}]}